Hannah Skingle

Dragonfly Biosciences

After topping the Tripos at King’s College London and completing a MSc in Management at the London School of Economics, Hannah Skingle spent her early years as an analyst at biotech company The RSA Group and prop-tech start-up Goodlord. Quickly moving to make her mark on Dragonfly Biosciences (one of Europe’s leading CBD companies), she progressed from Business Development Associate to Chief Operations Officer within a year.

Hannah plays a key role in building the company’s backend, with a clear focus on European Cannabis licensing and regulation. She’s an expert at the forefront of creating new policies and setting industry standards.